Abstract
High-dimensional medical datasets present challenges in feature selection, where traditional methods often prioritize spurious correlations over causally relevant variables, compromising model interpretability and clinical utility. We introduce CausalDRIFT, a causal feature selection algorithm grounded in the Frisch-Waugh-Lovell theorem and Double Machine Learning, which estimates the Average Treatment Effect (ATE) of each feature on clinical outcomes while adjusting for confounders. We evaluated CausalDRIFT against seven baseline methods (PCA, ICA, Elastic Net, RFE, etc.) across four datasets (Heart Disease, Diabetes, Breast Cancer, and PCOS) using XGBoost classifiers, with performance metrics including accuracy, precision, recall, and F1-score. CausalDRIFT achieved competitive performance, notably excelling in datasets with strong causal structure (e.g., 90% accuracy and F1-score of 0.90 on PCOS, outperforming most other methods). It demonstrated superior consistency (lowest standard deviation: 1.19 in Breast Cancer, lowest recall spread in Heart Disease) and robustness to confounding, though it traded marginal predictive gains for interpretability in correlation-dominated datasets. CausalDRIFT excels in high-dimensional, low-sample size (HDLSS) settings, such as the Breast Cancer dataset (569×32), where it achieves 93.9% accuracy and 91.8% F1-score. Statistical analysis (ANOVA, Tukey HSD) confirmed its recall performance was non-inferior to top methods (all p > 0.15), while unsupervised techniques like ICA significantly underperformed (p < 0.05). CausalDRIFT bridges the gap between causal inference and scalable feature selection, offering clinically interpretable and generalizable models. Its ability to prioritize causally actionable features is critical for high-stakes decision-making, and it makes it a promising tool for healthcare AI, particularly in settings like PCOS where etiology is complex.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study utilized 4 datasets from Kaggle, access link to the datasets is provided in the GitHub repository of this research, as stated in Experiments section.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
jarin.akter.mou{at}g.bracu.ac.bd
Data Availability
The study utilized 4 datasets from Kaggle, access link to the datasets is provided in the GitHub repository of this research, as stated in Experiments section.
